Design of a tripartite network for the prediction of drug targets

Drug-target networks have aided in many target prediction studies aiming at drug repurposing or the analysis of side effects. Conventional drug-target networks are bipartite. They contain two different types of nodes representing drugs and targets, respectively, and edges indicating pairwise drug-target interactions. In this work, we introduce a tripartite network consisting of drugs, other bioactive compounds, and targets from different sources. On the basis of analog relationships captured in the network and so-called neighbor targets of drugs, new drug targets can be inferred. The tripartite network was found to have a stable structure and simulated network growth was accompanied by a steady increase in assortativity, reflecting increasing correlation between degrees of connected nodes leading to even network connectivity. Local drug environments in the tripartite network typically contained neighbor targets and revealed interesting drug-compound-target relationships for further analysis. Candidate targets were prioritized. The tripartite network design extends standard drug-target networks and provides additional opportunities for drug target prediction.

[1]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[2]  Peteris Prusis,et al.  Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions , 2005, Bioinform..

[3]  Weida Tong,et al.  In silico drug repositioning: what we need to know. , 2013, Drug discovery today.

[4]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[5]  Salvatore Alaimo,et al.  Drug–target interaction prediction through domain-tuned network-based inference , 2013, Bioinform..

[6]  R. Iyengar,et al.  Systems approaches to polypharmacology and drug discovery. , 2010, Current opinion in drug discovery & development.

[7]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[8]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[9]  Yoshihiro Yamanishi,et al.  Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..

[10]  M. Rask-Andersen,et al.  Trends in the exploitation of novel drug targets , 2011, Nature Reviews Drug Discovery.

[11]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[12]  Veerabahu Shanmugasundaram,et al.  Molecular similarity measures. , 2011, Methods in molecular biology.

[13]  Jameed Hussain,et al.  Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..

[14]  Jean-Philippe Vert,et al.  Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..

[15]  Eugen Lounkine,et al.  Many Approved Drugs Have Bioactive Analogs With Different Target Annotations , 2014, The AAPS Journal.

[16]  Michael M. Hann,et al.  RECAP — Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. , 1998 .

[17]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[18]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[19]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[20]  Mark Newman,et al.  Networks: An Introduction , 2010 .

[21]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[22]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[23]  Jens Sadowski,et al.  Structure Modification in Chemical Databases , 2005 .

[24]  Tudor I. Oprea,et al.  Chemoinformatics in drug discovery , 2005 .

[25]  Alexander E. Ivliev,et al.  Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.

[26]  G. Maggiora,et al.  Molecular similarity measures. , 2004, Methods in molecular biology.

[27]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[28]  YamanishiYoshihiro,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008 .

[29]  Mengchun Chen,et al.  Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro , 2015, Drug development and industrial pharmacy.

[30]  Jürgen Bajorath,et al.  Matched molecular pairs derived by retrosynthetic fragmentation , 2014 .

[31]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[32]  William J. Welsh Chemoinformatics in Drug Discovery, Volume 23 , 2005 .

[33]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[34]  G. Maggiora,et al.  Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.